REPH - Recro Pharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $3.5. This is a potential upside of $3.5 (0%) from yesterday's end of day stock price of $0.

Recro Pharma's activity chart (see below) currently has 23 price targets and 13 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.25% with an average time for these price targets to be met of 110 days.

Most recent stock forecast was given by JEFF JOHNSON from BAIRD on 11-Aug-2020. First documented stock forecast 16-Sep-2016.

Best performing analysts who are covering REPH - Recro Pharma:

Leland Gershell David Amsellem Jeff Johnson Scott Henry

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$4.21 (532.91%)

18

3 years 7 months 17 days ago

2/4 (50%)

$3.59 (41.69%)

106

Buy

12

$11.21 (1418.99%)

18

3 years 10 months 16 days ago

3/6 (50%)

$7.12 (145.90%)

127

Buy

4 years 4 months 2 days ago

3/3 (100%)

$2.32 (40.35%)

197

Hold

6.73

$5.94 (751.90%)

5 years 3 days ago

1/4 (25%)

$0.98 (17.04%)

10

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is REPH (Recro Pharma) average time for price targets to be met?

On average it took 110 days on average for the stock forecasts to be realized with a an average price target met ratio 56.25

Which analyst has the current highest performing score on REPH (Recro Pharma) with a proven track record?

LELAND GERSHELL

Which analyst has the current lower performing score on REPH (Recro Pharma) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on REPH (Recro Pharma)?

Leland Gershell works at OPPENHEIMER and has 23 price targets and 11 ratings on REPH

Which analyst is the currently most bullish on REPH (Recro Pharma)?

Leland Gershell with highest potential upside - $11.21

Which analyst is the currently most reserved on REPH (Recro Pharma)?

David Amsellem with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?